Pfizer Inc
Trump could make changes to Medicare drug price negotiations
President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, ...
Reid Hoffman launches Manas AI, a new drug discovery startup
Reid Hoffman, Partner at Greylock and co-founder LinkedIn, speaks during the WSJ Tech Live conference hosted by the Wall Street ...
Nvidia, tariffs make for a confusing market. Here’s my advice for investors
“My pathway led by confusion boats / mutiny from stern to bow.” That phrase, from Bob Dylan’s 1964 classic, “My ...
Trump health care plan likely good for pharmaceutical companies
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the ...
Biotech, pharma M&A picks up in 2025
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of ...
Medicare drug price negotiations list includes Ozempic
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, ...
Jim Cramer addresses Nvidia’s recent 14% decline and what he’s doing with the stock
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a ...
Merck signs weight loss pill licensing deal with Hansoh Pharma
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty ...
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of ...
Pfizer’s cancer cachexia drug shows positive midstage trial results
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
